A research team introduces a fully automated, non-destructive phenotyping platform that combines X-ray fluorescence ...

Twenty-five years of research into complex systems shows why artificial intelligence will always produce errors in healthcare decisions, regardless of technological improvements or funding.

LLY, MDT, ISRG, REGN and JNJ are five defensive medical stocks using AI to drive growth, diagnostics and innovation into 2026.

India's first government-run artificial intelligence (AI) clinic, launched recently at the Government Institute of Medical ...

New digital health system promises big gains in screening and treatment, but critics warn it increases the risks of data ...

Accurately predicting complex agronomic traits remains a major bottleneck in crop breeding. This study demonstrates how ...

GE HealthCare Technologies Inc. (NYSE: GEHC) leads with 100 FDA-approved AI devices, concentrating heavily on imaging and diagnostics. Their CleaRecon DL technology sharpens cone-beam CT images using ...

Structural variations (SVs)—large-scale changes in DNA sequence—play a crucial role in shaping traits such as yield, quality, and environmental adaptation in crops.

University of Otago scientists are harnessing the power of peptides—the body's own tiny protein molecules—for a spray to help ...

One of the most immediate impacts of AI in medical genetics lies in diagnosis, particularly for rare and complex genetic ...

Credit: Getty Images Federal legislation introduced in early 2025 proposed allowing AI to prescribe medication. The Conversation — In the past decade, the success of artificial intelligence (AI) has ...